Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos

Articles by Eileen Koutnik-Fotopoulos

Eileen Koutnik-FotopoulosNon-Small Cell Lung Cancer | April 19, 2024
Positive trial results and FDA approvals have changed the standard of care for NSCLC.
Read More
Eileen Koutnik-FotopoulosLung Cancer | April 16, 2024
Researchers looked at unique features in epidemiology, risk factors, and biology of lung cancer in women.
Eileen Koutnik-FotopoulosLung Cancer | March 20, 2024
A gap remains in understanding how lung cancer risk may be impacted by structural racism.
Eileen Koutnik-FotopoulosLung Cancer | March 19, 2024
Diagnosing early-stage lung cancer with low-dose CT screening has shown significantly improved cure rates.
Eileen Koutnik-FotopoulosLung Cancer | March 15, 2024
Researchers evaluated the impact of exercise and tai chi on quality life in patients with advanced lung cancer.
Eileen Koutnik-FotopoulosNon-Small Cell Lung Cancer | February 28, 2024
Researchers evaluated the safety, tolerability, and antitumor activity of Dato-DXd in treating NSCLC.
Eileen Koutnik-FotopoulosLung Cancer | February 26, 2024
Removal of race correction in PFTs is a priority to address the inappropriate use of race within algorithms.
Eileen Koutnik-FotopoulosNon-Small Cell Lung Cancer | February 20, 2024
The effect of genomic alterations in NSCLC on brain metastases remains unclear.
Eileen Koutnik-FotopoulosNon-Small Cell Lung Cancer | January 26, 2024
Researchers examined the demographic and clinical outcomes in patients with KRAS-mutated tumors, using patients with NSCLC.
Eileen Koutnik-FotopoulosNon-Small Cell Lung Cancer | January 26, 2024
The optimal duration of ICI ± chemotherapy for patients with advanced non-small cell lung cancer remains unclear.
Eileen Koutnik-FotopoulosLung Cancer | January 26, 2024
Potential disparities in lung cancer among other racial and ethnic groups in the United States have been poorly examined.
Eileen Koutnik-FotopoulosLung Cancer | January 3, 2024
Researchers assessed the benefits and safety of biomarker-driven thromboprophylaxis among patients with lung and GI cancers.
Eileen Koutnik-FotopoulosLung Cancer | December 27, 2023
A study assessed the clinical benefits and safety of thromboprophylaxis among patients with lung and GI cancers.
Eileen Koutnik-FotopoulosSmall Cell Lung Cancer | December 27, 2023
A study analyzed the efficacy and safety of radiotherapy in patients with SCLC with brain metastases.
Eileen Koutnik-FotopoulosLung Cancer | December 22, 2023
Exposure to wildfire smoke has been shown to decrease the chances of lung cancer survival.